Approval · Notice of Compliance 26592 · 2021
VELPHORO: Notice of Compliance 26592
Issued September 2, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26592
- Date
- September 2, 2021
- Company
- Vifor Fresenius Medical Care Renal Pharma LtdSt Gallen, St Gallen, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph with addition of information from a post-market non-interventional study
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELPHORO | Not yet assigned | — |
Medicinal ingredients
- SUCROFERRIC OXYHYDROXIDE 2,500 MG per TAB